EDGAR·FLOW

Most material SEC filings — November 19, 2026

50 filings analyzed. Top movers: LUXFER HOLDINGS PLC, HeartSciences Inc., PERMIAN BASIN ROYALTY TRUST, Onfolio Holdings, Inc, Fathom Holdings Inc..
8-K LUXFER HOLDINGS PLC
Wynnchurch Capital completed its all-cash acquisition of Luxfer Holdings PLC on November 19, 2026, at $17.37 per ordinary share. The transaction was announced July 27, 2026, approved by shareholders November 4, 2026, and received regulatory approvals and High Court sanction. Luxfer is now private and delisted from NYSE; the transaction value is approximately $566M (based on ~32.6M shares outstanding at $17.37/share).
▼ Likely negative · significance 95 · 8-K Agent
8-K HeartSciences Inc.
HeartSciences Inc. (market cap ~$10.4M) entered an Equity Distribution Agreement dated November 18, 2026 with Maxim Group LLC to offer up to $50,000,000 of common stock on an at-the-market basis under Form S-3. The offering size is 4.8× the company's current market capitalization. Maxim will act as exclusive sales agent at a 2.5% commission (or 2.0% if Form S-3 limitations cease). No shares have been sold yet; the agreement permits continuous sales over three years, with the company controlling timing and pricing via transaction notices.
▲ Likely positive · significance 92 · 8-K Agent
8-K PERMIAN BASIN ROYALTY TRUST
Permian Basin Royalty Trust declared a November cash distribution of $0.020923 per unit (payable 12/14/2026 to 46.6M units outstanding), generating $975,218 after $153,960 G&A expenses. Texas Royalty Properties contributed $1.13M (oil $86.30/bbl, gas $10.67/Mcf; volumes down YoY); Waddell Ranch properties remain in excess-cost position (Production Costs exceeded Gross Proceeds in October, so zero distribution from that asset). Most significantly, a Special Meeting is scheduled for November 23, 2026, where unitholders will vote on a proposed Business Combination with Blackbeard Holdings entities—if approved, the Trust would convey substantially all assets to new publicly traded corporation PBT Land and Minerals, Inc., and unitholders would receive one share of Class A common stock per unit held; the Trust would then terminate and cease SEC reporting.
▲ Likely positive · significance 92 · 8-K Agent
8-K Onfolio Holdings, Inc
Onfolio Holdings, Inc (market cap ~$4.2M) filed an 8-K on November 19, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing does not disclose specific reasons, cure periods, or remediation plans in the available text. This represents a critical corporate governance event for a micro-cap company.
▼ Likely negative · significance 92 · 8-K Agent
8-K Fathom Holdings Inc.
Fathom Holdings Inc. filed an 8-K on 2026-11-19 disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing indicates the company has failed to meet continued listing requirements, though the specific rule violated and remediation timeline are not detailed in this document header. This represents a critical corporate development for the $21.9M market cap company.
▼ Likely negative · significance 92 · 8-K Agent
8-K NATURAL HEALTH TRENDS CORP
On November 16, 2026, Natural Health Trends Corp (market cap ~$32.4M) filed an 8-K reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing provides notice of a delisting event but does not specify which exchange, the particular listing standard violated, or remediation timeline in the extracted text provided.
▼ Likely negative · significance 92 · 8-K Agent
8-K EAGLE FINANCIAL SERVICES INC
Eagle Financial Services (EFSI) and John Marshall Bancorp shareholders approved the merger announced September 8, 2026. Upon completion, the combined company will have ~$4.3B in total assets. EFSI (assets $1.9B, deposits $1.6B) will merge into John Marshall (assets $2.4B, deposits $2.1B). Transaction remains subject to Virginia state banking regulator approval; Federal Reserve already approved the bank-level merger.
▲ Likely positive · significance 92 · 8-K Agent
8-K Passage BIO, Inc.
Remix Therapeutics is merging with Passage Bio in a reverse recapitalization. Remix raised $100M via $30M convertible notes (June 2026) and $70M subscription financing (received by Nov 17, 2026). Exchange agreements converted 85.1M preferred shares and 3M common shares into pre-funded warrants. Post-merger, combined company valued at ~$352.7M with Remix shareholders holding 63%, new investors 29.5%, Passage Bio shareholders 7.5%.
▲ Likely positive · significance 92 · 8-K Agent
8-K MACH NATURAL RESOURCES LP
Mach Natural Resources LP entered into a second lien credit agreement dated November 19, 2026 with Sixth Street Lending Partners as administrative agent. The facility provides $385 million in term loans with a 2% original issue discount, maturing December 31, 2030. Loans bear interest at Term SOFR plus 5.25% margin (or ABR plus 4.25%), with subordination to existing first lien facility and comprehensive collateral securing oil and gas reserves.
▲ Likely positive · significance 91 · 8-K Agent
8-K/A LISATA THERAPEUTICS, INC.
On September 17, 2026, Lisata Therapeutics acquired Marea Therapeutics for approximately $377.8M in consideration consisting of 1,793,129 common shares (~19.9% of pre-merger outstanding) and 211,365 Series C Preferred shares (convertible 1:1000 to common). Concurrently, a $225M PIPE closed on September 18, 2026 via 150,868 Series C Preferred shares at $1,491.37/share. Post-conversion (pending stockholder approval), Marea shareholders hold ~59.5%, PIPE investors ~38.1%, and legacy Lisata shareholders ~2.4% of fully diluted shares.
▲ Likely positive · significance 78 · 8-K Agent
8-K HYSTER-YALE, INC.
Hyster-Yale priced $135M aggregate principal of 7.50% Convertible Senior Notes due November 15, 2031 (upsized from $125M announced), with an initial conversion price of $18.14/share (17.5% premium to $15.44 closing price on Nov 18, 2026) and initial conversion rate of 55.1207 shares per $1,000 principal. Net proceeds (~$129.7M, or ~$149.1M if underwriters exercise $20M option) will repay $110M of term loan debt, fund $13.5M capped call hedges, repurchase ~971K shares (~$15M at $15.44/share), and support general corporate purposes. Closing scheduled for Nov 23, 2026.
— Neutral · significance 72 · 8-K Agent
8-K Vivid Seats Inc.
Vivid Seats Inc. entered into a Transaction Support Agreement (TSA) with an ad hoc group of term loan lenders on November 19, 2026, to execute a comprehensive recapitalization. The transaction involves exchanging ~$273M in existing term loan debt for ~45.8M newly issued Class A common shares (~80% pro forma equity), reducing net debt by ~$232M (from $342M to ~$110M), extending loan maturity to January 2032, and providing $60M of new first lien term loans plus $6M in paid-in-kind fees. Existing shareholders retain ~20% equity (~11.5M shares). Expected closing Q1 2027.
▲ Likely positive · significance 72 · 8-K Agent
8-K Pyxis Oncology, Inc.
Pyxis announced updated Phase 1 monotherapy results for MICVO in second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma as of October 14, 2026 (N=33 efficacy-evaluable patients dosed at 5.4 mg/kg Q3W with dose cap). Key data: 39% confirmed ORR, 94% disease control rate, 6.7-month median PFS (vs. 4.2 months on prior therapy—a 50% improvement), 9.2-month median duration of response, and 81% 12-month OS probability. Safety: manageable; six Grade 3 peripheral neuropathy cases all resolved or improved. Company plans Phase 3 initiation mid-2027.
▲ Likely positive · significance 72 · 8-K Agent
8-K Warner Music Group Corp.
Warner Music Group reported fiscal 2026 (ended September 30, 2026) with total revenue of $7,437M (+11% YoY; 9% constant currency), Adjusted OIBDA of $1,770M (+23% YoY; 19% constant currency), and net income of $735M (+99% YoY). Recorded Music revenue reached $5,987M (+11%) driven by 13.5% subscription streaming growth and market share gains; Music Publishing revenue was $1,455M (+11%). Adjusted OIBDA margin expanded 230 basis points to 23.8%. Free cash flow increased 42% to $766M. Net debt increased to $4,115M from $3,833M, partly due to $303M Tempo Music acquisition debt and $363M Beethoven JV loans (both nonrecourse).
▲ Likely positive · significance 72 · 8-K Agent
8-K UGI CORP /PA/
UGI Corporation's Board unanimously approved a plan to separate its Global LPG business (AmeriGas Propane + UGI International) into a standalone publicly traded company, intended to be tax-free to shareholders. The separation targets completion in H2 2027; UGI may retain up to 19.9% and exit within 12 months post-launch. The resulting 'New UGI' will focus on regulated natural gas utilities (~$4.7B rate base in PA/WV) and complementary midstream assets; Global LPG will be the world's largest publicly traded LPG distributor with ~$740M FY26 EBITDA and 1.5B gallons sold annually.
▲ Likely positive · significance 72 · 8-K Agent
8-K UGI CORP /PA/
UGI Corporation's Board unanimously approved a plan to separate its Global LPG business into an independent publicly traded company via tax-free spinoff expected to close in H2 2027. Post-separation, New UGI will focus on regulated natural gas utilities (700k PA customers, 209k WV customers) and midstream assets with 8-10% annual rate base growth; the new LPG Company will operate as the world's largest publicly listed LPG distributor, serving 950k US propane customers plus European operations across 9 countries. UGI may retain up to 19.9% of the new LPG Company, exiting tax-efficiently over time.
▲ Likely positive · significance 72 · 8-K Agent
8-K Medicus Pharma Ltd.
Medicus Pharma received Nasdaq confirmation (Nov 18, 2026) of regained compliance with the $2.5M minimum shareholders' equity listing requirement. The company raised ~$4.25M in equity ($3.0M registered direct offering + ~$1.25M insider placements including $750K from CEO Dr. Raza Bokhari) and exchanged $10.5M of debt held by Streeterville Capital for non-convertible preferred shares. Compliance is conditional; the company must evidence continued compliance by Dec 31, 2026 or face delisting.
▲ Likely positive · significance 72 · 8-K Agent
8-K All In FutureTech Alliance, Inc.
All In FutureTech Alliance, Inc. (public market value ~$38.3M) is acquiring 100% of Little Vault Inc. from Li Shanglong (who becomes CEO) for US$8 million, payable as 1,280,000 AIFA Common Stock shares (~19.94% of issued shares) at US$6.25/share. The acquisition includes exclusive commercialization rights to Seller Personal IP (Li's identity, content, accounts) through an IP Cooperation Agreement. Li receives a 12-month lock-up on shares; a 'Triggering Breach' of IP revenue obligations allows Buyer to reverse the entire transaction (return shares, retake Little Vault) plus pursue monetary damages. The agreement contains extensive IP control, revenue allocation, and related-party governance provisions given Li's dual role as director/chairman and seller.
▲ Likely positive · significance 72 · 8-K Agent
8-K Aptera Motors Corp
Aptera Motors completed its first production vehicle on November 19, 2026, built for early investor Martin Hartono (Accelerator #1) in Noir matte black finish. The vehicle will be exported outside the US. This represents the company's first customer delivery of its three-wheeled solar electric vehicle after years of development.
▲ Likely positive · significance 72 · 8-K Agent
SCHEDULE 13D Brookdale Senior Living Inc.
Carronade Capital Management LP and Dan Gropper accumulated 3,896,747 net shares of Brookdale Senior Living (BDRX) over 60 days ending November 18, 2026, at prices ranging $8.74–$10.96/share, totaling approximately $35–37M. On November 6, 2026, they also entered long call options on 3,000,000 additional shares at $8.88/share. A large convertible note conversion (77,428 shares at settlement) and significant selling on 11/6 (1.45M shares at $8.88) bookended a sustained accumulation pattern, suggesting material activist positioning in a $1.6B market-cap company.
▲ Likely positive · significance 72 · Ownership Agent
8-K bioAffinity Technologies, Inc.
bioAffinity Technologies reported 109% year-to-date growth in CyPath Lung test unit sales through Q3 2026, with 89% increase in ordering physicians and 48% growth from repeat customers. The company raised $4M via registered direct offering at market prices in October 2026. New distribution agreement with AvMEDICAL provides access to VA medical centers and federal healthcare facilities nationwide; this partnership does not itself represent completed sales. Company also expanded patent portfolio in Hong Kong, China, and Japan, and is advancing asthma/COPD diagnostic development.
▲ Likely positive · significance 72 · 8-K Agent
8-K Beeline Holdings, Inc.
Beeline Holdings (BLNE, public market value ~$23.8M) agreed to merge with TYTL Corp, a private company, via stock-for-stock transaction dated November 19, 2026. TYTL shareholders receive BLNE Common Stock at an Exchange Ratio tied to fully-diluted capitalization of both companies. BLNE must obtain stockholder approval (including Majority of Minority vote) and listing approval; TYTL must secure $15M in qualifying financing pre-closing. Transaction includes lock-up agreements, side letter with CEO Nicholas Liuzza (forfeits 1/3 of merger consideration), and post-closing board designation rights for TYTL holders (if they retain ≥10% ownership).
▲ Likely positive · significance 72 · 8-K Agent
8-K Game Your Game Inc.
Game Your Game completed a direct listing on Nasdaq (ticker GYGY) on July 30, 2026, transitioned GameGolf KZN AI to full commercial availability on September 23, 2026, and formed Altus Sports Group (70% owned) for talent representation and sports marketing. Q3 2026 revenue was $106,813 (up 315% YoY, but 98% from single reseller GolfSuites); nine-month net loss attributable to common stockholders was $9.27M ($0.63 per share). Cash position improved from $87K (Dec 2025) to $4.4M (Sept 2026) due to listing proceeds, but company burned $3.86M in operating cash in nine months. Series A Preferred Stock (26,000 shares outstanding, liquidation preference $31M) triggered a contingent dividend event on September 14 when stock price fell below threshold, increasing stated value by $1.44M and creating substantial dilution risk.
▼ Likely negative · significance 72 · 8-K Agent
8-K Sizzle Acquisition Corp. II
Sizzle Acquisition Corp. II (public market cap ~$233M) announced a business combination with Trasteel Holding S.A., a Luxembourg-based global steel trading and industrial platform. Pro forma enterprise value is ~$975M (at 0–100% redemption scenarios). Trasteel generated $1.926B revenue and $68M EBITDA in FY2025 (Swiss GAAP); Sizzle will contribute ~$200M cash (net of ~$30M fees). Trasteel existing shareholders roll over 100% equity; post-close ownership: Trasteel 70.4%, Sizzle public ~22.3%, others ~7.3%. Deal expected to close in late 2026; Trasteel projects FY2027 revenues $2.1–2.5B, EBITDA $80–85M.
▲ Likely positive · significance 72 · 8-K Agent
8-K SmartKem, Inc.
SmartKem's Board approved and implemented a 1-for-5 reverse stock split, reducing outstanding shares from approximately 5,039,472 to 1,007,895 shares. The split became effective November 20, 2026, with trading on split-adjusted basis beginning November 23, 2026 under ticker SMTK. The reverse split was intended to support continued Nasdaq listing compliance and proportionally adjusts all equity awards, warrants, and convertible securities; shareholders' ownership percentages unchanged except for fractional share rounding.
▼ Likely negative · significance 72 · 8-K Agent
8-K AIR INDUSTRIES GROUP
Air Industries Group announced November 19, 2026, that it is postponing both a planned 1-for-5 reverse stock split and a dividend of non-transferable redemption rights originally scheduled for November 27, 2026, in connection with its proposed merger with Tenax Aerospace Acquisition, LLC. The special stockholder meeting to vote on the merger was rescheduled from November 18, 2026, to December 3, 2026, at 10:00 a.m. ET. The merger was originally announced November 10, 2026; the definitive proxy statement/prospectus was filed with the SEC on November 6, 2026.
— Neutral · significance 72 · 8-K Agent
8-K Sports Entertainment Gaming Global Corp
SEGG Media cancelled its stock purchase and registration rights agreement with Generating Alpha Ltd (originally Nov 2024, amended June 2025) to reduce shareholder dilution and market overhang. The company is replacing this $300M equity line of credit with alternative financing commitments: International Gaming Alliance will fund Lottery.com's global affiliate expansion (launched Nov 18, 2026), and SEGG secured separate undisclosed financing for Veloce Media Group, Quadrant, and rollouts of Sports.com, Concerts.com, and TicketStub.com. This follows the company's January 2026 exit from UCIL financing.
▲ Likely positive · significance 72 · 8-K Agent
SCHEDULE 13D/A PRF Technologies Ltd.
S.H.N. Financial Investments Ltd., holding 200,000 ordinary shares (5.716% of voting rights), demands inclusion of four resolutions on PRF's December 21, 2026 annual general meeting agenda: removal of directors Dr. Ehud Geller, Efi Cohen-Arazi, and Asaf Shavit, and election of three replacements (Margarita Hirsch Malahovich, Liat Katzman, Amos Pickel). The Company had excluded these proposals despite a pending court motion. S.H.N. threatens court action to compel inclusion and cost recovery if the Company does not confirm compliance by November 17, 2026.
▼ Likely negative · significance 72 · Ownership Agent
8-K POWER SOLUTIONS INTERNATIONAL, INC.
Power Solutions International engaged Anchor Resource Management to provide Robert Losier as Interim CFO, effective November 16, 2026. Losier will be appointed as PSI officer reporting to CEO Richard Hu, working full-time on-site at $40,000/week ($2.08M annualized), with an $80,000 retainer. PSI may terminate on 7 days' notice; if hired permanently within 12 months, PSI pays Anchor 20% of first-year base salary (declining to 10% after week 26, then 0% after week 52).
▼ Likely negative · significance 72 · 8-K Agent
8-K Scienture Holdings, Inc.
Scienture Holdings (market cap ~$10.2M) reported Q3 2026 revenue of $1.25M, up 265% sequentially from $344K in Q2 and 113% YoY from $590K in Q3 2025. REZENOPY (naloxone nasal spray) launched in August 2026 and generated ~$925K in Q3 net product revenue; Arbli (losartan suspension) contributed ~$330K. The company achieved Q3 gross profit of $1.02M (81.3% margin) and narrowed 9-month net loss to $12.2M from $13.4M YoY. Cash position improved to $7.8M (including $3M restricted cash) from $6.7M at year-end 2025. Management expects breakeven operating income and profitability in 2027 based on current sales trajectory.
▲ Likely positive · significance 72 · 8-K Agent
8-K Aimei Health Technology Co., Ltd.
Aimei Health Technology amended its Investment Management Trust Agreement on November 19, 2026, extending the deadline to complete a business combination from 36 months to 48 months from IPO closing, approved by shareholders on November 10, 2026. The extension requires the company to deposit $80,000 per month (or $0.033 per outstanding public share, whichever is less) into the trust account for each one-month extension. The trust account contains funds held for public shareholders that must be used for a qualifying business combination or returned if the deadline expires.
▼ Likely negative · significance 72 · 8-K Agent
8-K Keysight Technologies, Inc.
Keysight delivered full-year FY2026 revenue of $7.16 billion (up 33% from $5.37 billion in FY2025) and GAAP net income of $1.51 billion, or $8.75 per diluted share (up 78% from $4.91). Q4 revenue was $1.99 billion (up 41% YoY). Communications Solutions Group revenue grew 51% in Q4; Electronic Industrial Solutions Group grew 16%. Free cash flow for FY2026 was $1.75 billion vs. $1.28 billion prior year. Cash position increased to $2.92 billion. Management guided Q1 FY2027 revenue of $2.04–2.06 billion and non-GAAP EPS of $3.63–3.69.
▲ Likely positive · significance 72 · 8-K Agent
8-K ESCO TECHNOLOGIES INC
ESCO Technologies reported FY 2026 sales of $1.32 billion (+21% YoY), with adjusted EPS of $8.42 (+40% YoY) and record backlog of $1.5 billion. The Megger acquisition closed October 1, 2026 (after fiscal year-end); FY 2027 guidance expects sales of $2.05–$2.09 billion (+55–58%), with USG segment revenue increasing 170–175% from $640–$660 million Megger contribution. Adjusted EBIT margin guidance: 21.2–21.8% in FY 2027. Operating cash flow from continuing operations was $296 million in FY 2026 (+$95M YoY).
▲ Likely positive · significance 72 · 8-K Agent
8-K/A IMMUCELL CORP /DE/
ImmuCell posted Q3 2026 net income of $953K ($0.10/diluted share) vs. loss of $140K in Q3 2025, with product sales growing 46% to $8.0M and gross margin expanding 130 bps to 44.2%. Cash increased to $7.9M (from $3.8M year-end 2025) benefiting from a $2M settlement received in May 2026. The company negotiated a new $3M line of credit (expected Q4 2026 signing) and terminated its At-The-Market offering, citing strong cash position.
▲ Likely positive · significance 72 · 8-K Agent
8-K iQSTEL Inc
IQSTEL generated $313.0M consolidated revenue in nine months 2026 (up 34.5% YoY, all organic), with Telecom segment revenue of $277.6M and $1.31M operating income. The company announced a proposed 51% acquisition of Ultranet Telecom (West African operator with $130.9M 2025 revenue, $5.0M EBITDA), targeting Q1 2027 close, financed via senior secured notes and $420K pre-funded warrants. Stockholders' equity stands at $17.67M; cash position $2.95M. CEO targets 2027 milestones: combined $500M+ annualized revenue run-rate, ~$9M Operating Adjusted EBITDA, and Q1 2027 commercial launch of IQSTEL Digital microdrama service (targeting 300K paid subscriptions by year-end).
▲ Likely positive · significance 72 · 8-K Agent
8-K John Marshall Bancorp, Inc.
John Marshall Bancorp (JMSB, $231.6M market cap) and Eagle Financial Services (EFSI) announced shareholder approval on November 19, 2026, for their merger announced September 8, 2026. The combined entity will have ~$4.3B in assets (JMSB currently $2.4B + EFSI $1.9B). The transaction requires approval from Virginia Bureau of Financial Institutions; Federal Reserve already approved the bank-level merger. No deal consideration (stock ratio, cash, or per-share price) is stated in this filing.
▲ Likely positive · significance 72 · 8-K Agent
8-K Inogen Inc
Kevin Smith, an officer and director of Inogen Inc., separated from the company effective October 30, 2026. Under the separation agreement executed November 16, 2026, Smith receives: (1) $1,469,700 in salary severance paid over 24 months at $61,237.50/month; (2) COBRA health benefits continuation; (3) prorated 2026 annual bonus of $610,026.16 based on performance goals; and (4) acceleration of equity awards vesting on December 1, 2026. Smith resigned from all director and officer positions and released all claims against the company.
▼ Likely negative · significance 72 · 8-K Agent
8-K HALLADOR ENERGY CO
On November 18, 2026, the Indiana Utility Regulatory Commission approved Hallador's 12-year capacity agreement with a utility subsidiary, effective immediately. The contract, originally signed May 1, 2026, generates >$1B in capacity revenue from the Merom Generating Station through mid-2040 at pricing >2x historical rates; deliveries begin late 2028 at reduced volume, scaling to ~two-thirds accredited capacity from 2029 onward. Energy sales remain separately available, and the approval brings Hallador's total forward sales book to ~$3B.
▲ Likely positive · significance 72 · 8-K Agent
8-K Spectral AI, Inc.
On November 13, 2026, Spectral AI (market cap ~$72M) executed a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. (Yorkville Advisors), enabling the company to issue up to $15 million in common stock at the company's discretion over 24 months or until the commitment is exhausted. The investor is capped at 4.99% ownership and cannot purchase above 19.99% of outstanding shares without stockholder approval; Spectral AI must pay Yorkville a $15,000 structuring fee. This is Spectral AI's second SEPA with the same investor (a 2024 SEPA also exists). The agreement is registered on Form S-3 (File 333-282681, effective October 31, 2024) and was disclosed via Form 8-K and prospectus supplement on November 19, 2026.
▲ Likely positive · significance 72 · 8-K Agent
8-K Verastem, Inc.
Verastem engaged Michael Bailey as a consultant effective November 17, 2026, to advise leadership on CEO transition. Bailey will receive $40,000/month ($80,000 total) for November–December 2026 as an independent contractor, with appointment as President and CEO effective January 1, 2027. The consulting agreement is a bridge arrangement with standard confidentiality, non-disclosure, and equity compliance provisions.
▲ Likely positive · significance 72 · 8-K Agent
8-K STANDARD BIOTOOLS INC.
Standard BioTools stockholders approved the merger with Treeline Biosciences and concurrent sale of the Mass Cytometry business to GMT Venture Partners' Element Biosystems at a special meeting on November 19, 2026. The Treeline merger is expected to close in Q4 2026. No specific financial terms or stake percentages are disclosed in this announcement, only the approval of the transactions and two new equity plans (Post-Closing Equity Incentive Plan and Employee Stock Purchase Plan).
▲ Likely positive · significance 72 · 8-K Agent
8-K PharmaCyte Biotech, Inc.
PharmaCyte Biotech (Holder) exchanged 851,304 Series G Long-Term Warrants for 4,982,272 shares of common stock in Q/C Technologies, Inc. effective November 15, 2026. As majority holder of Q/C's Series H Preferred Stock (3,000,000 shares), PharmaCyte also consented to extend the Series H maturity date by six months from March 2, 2027 to September 2, 2027. PharmaCyte received demand registration rights for resale of the shares.
▲ Likely positive · significance 72 · 8-K Agent
8-K Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals amended its April 30, 2026 Securities Purchase Agreement with investors (representing ≥67% of purchasers). Key changes: (1) Lowered the Milestone Event threshold from 2,000 to 500 (likely units or operational metric); (2) Modified the second milestone to require 90% fleet operational uptime for 7 consecutive days by February 1, 2027 or within 60 days of mining rig operations commencing; (3) Staggered registration statement deadlines for Conversion Shares/Warrant Shares (by Jan 31, 2027) and Milestone Shares in three equal tranches (Mar 1, Apr 1, May 1, 2027); (4) Waived prior registration failures. Dollar amounts and total share counts are not disclosed in the filing.
▼ Likely negative · significance 72 · 8-K Agent
8-K GEOSPACE TECHNOLOGIES CORP
Geospace reported fiscal year 2026 revenue of $80.7M (down from $110.8M in FY2025) and a net loss of $44.3M or $(3.43) per share (vs. $(0.76) in FY2025). Key drivers: Smart Water segment revenue fell 52% to $17.2M due to Hydroconn connector weakness; Energy Solutions declined 19% to $40.9M from lower marine node utilization, partially offset by Petrobras PRM contract work; Intelligent Industrial fell 7% to $22.2M. The company took $6M in non-cash charges (cumulative foreign exchange losses and equipment impairments), executed two reduction-in-force events, and secured a new $25M revolving credit facility from Amerisource Funding (prime + 3.5%, replacing $7.5M Woodforest debt). Management touts $100M+ backlog and cost restructuring for FY2027 recovery.
▼ Likely negative · significance 72 · 8-K Agent
8-K Stewards, Inc.
On November 19, 2026, Stewards, Inc. created and issued 7,000,000 shares of Series D Convertible Preferred Stock (stated value $3.00/share = $21.0M total) to sellers Envy Development PB, LLC (6,766,900 shares) and The Myelin Group, LLC (233,100 shares) in exchange for cancellation of 7,000,000 common shares held in escrow. The Series D is convertible 1:1 into common stock, senior to common stock and Series B preferred on liquidation, junior to Series A preferred and all debt, carries no dividend, and includes a liquidity review right trigger on April 5, 2027 if shares remain outstanding.
— Neutral · significance 72 · 8-K Agent
8-K Inflection Point Acquisition Corp. VI
Inflection Point Acquisition Corp. VI (IPFX, $257.9M total assets) is completing its business combination with Quantum Space, LLC, a spacecraft development company. The combined entity will be renamed Quantum Space, Inc. and delist from Nasdaq on November 20, 2026, then list on NYSE under ticker QSPC and warrants on NYSE American under QSPC WS, with trading expected to commence November 24, 2026. Shareholder vote is scheduled for November 20, 2026; closing is expected November 23, 2026. No specific valuation, share count, or consideration amounts are disclosed in this filing.
— Neutral · significance 72 · 8-K Agent
8-K GeoVax Labs, Inc.
GeoVax Labs engaged BPC Consulting Ltd. (Anna Skowron, designee) as fractional CFO at $10,000/month effective November 16, 2026, and Tyler O'Brien as CEO consultant at $15,000/month backdated to November 5, 2026. Both are independent contractors with 90-day termination notice; compensation covers basic duties with performance bonuses possible. Prior agreements with both parties are waived.
— Neutral · significance 72 · 8-K Agent
S-1 DATA I/O CORP
On October 20, 2026, Data I/O closed a private placement raising approximately $13.25 million gross proceeds. The company issued 746,266 common shares at $2.68/share and ~$11.25 million in five-year convertible debentures (5% interest, maturing October 2031). Approximately $7.25M principal converts to common at $2.68/share; ~$4.0M converts to Series C Preferred Stock at $1,000/share (then to common at $2.68/share). Nine accredited investors participated. Ladenburg Thalmann earned 7% cash fee plus 1% management fee. This Form S-1 registers 4,944,025 shares for resale by nine selling stockholders (including Lytton-Kambara Foundation holding 33.51% post-offering). Company receives no proceeds from resales; net proceeds fund an announced acquisition and working capital.
▲ Likely positive · significance 72 · Registration Agent
SCHEDULE 13D/A SEACOR Marine Holdings Inc.
Between 10/16/2026 and 11/17/2026, an insider executed mixed transactions totaling approximately 1.66M shares sold (net) at prices ranging from $7.52–$9.44 per share. The largest single sale was 516,815 shares at $7.52/share on 11/16/2026. This represents a significant reduction in the filer's stake and signals reduced confidence or rebalancing.
▼ Likely negative · significance 72 · Ownership Agent
8-K Merlin, Inc.
Matthew George resigned as Chief Executive Officer and Chairman effective November 18, 2026, transitioning to Founder and Advisor role. Bob Smith, a Blue Origin veteran, was appointed interim CEO and Chairman. George receives $937,500 severance paid over 18 months, $625,000 bonus, 18 months COBRA subsidy, and continued equity vesting during a one-year advisory period at $6,250/month. Smith receives $48,000/month base salary plus 2.0M RSUs (500K vesting at 6 months, 1.5M vesting monthly over 12 months, with 1M minimum vesting if term ends early).
— Neutral · significance 68 · 8-K Agent
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.